Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II)
暂无分享,去创建一个
Shuntaro Sato | Hiroshi Yamamoto | S. Kawashiri | A. Kawakami | N. Hosogaya | S. Morimoto | R. Sumiyoshi | Shigeki Tashiro | Y. Kawazoe | T. Shimizu | Shuri Minoda | S. Kuroda